Fresenius Medical Care AG & Co. KGaA (ETR:FME) Receives €64.00 Price Target by Jefferies Financial Group Analysts

0

Jefferies Financial Group has set a target price of €64.00 ($66.67) on Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) in a research note published on Monday, Borsen Zeitung reports.

A number of other analysts have also weighed in on the company recently. Warburg Research set a price target of €62.00 ($64.58) on Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, May 10. Barclays set a price target of €68.00 ($70.83) on Fresenius Medical Care AG & Co. KGaA in a Wednesday, June 22 report. Goldman Sachs Group set a price target of €71.00 ($73.96) at Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 report. Berenberg Bank set a price target of €82.20 ($85.63) on Fresenius Medical Care AG & Co. KGaA in a Monday, June 27 report. Finally, Deutsche Bank Rese… set a price target of €58.00 ($60.42) on Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 report.

Shares of ETR FME open at €47.66 ($49.65) on Monday. The 50-day moving average share price is €54.13 and its 200-day moving average price is €57.12. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €43.53 ($45.34) and a 52-week high of €71.14 ($74.10). The stock has a market capitalization of $13.97 billion and a P/E ratio of 15.97. The company has a quick ratio of 0.79, a current ratio of 1.26 and a debt ratio of 91.78.

About Fresenius Medical Care AG & Co. KGaA (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Featured articles



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.